New Haven Clinical Site - Site 01 — New Haven, Connecticut

New Haven Clinical Site - Site 01 is a clinical research site located in New Haven, Connecticut, United States.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

New Haven Clinical Site - Site 01 has participated in 1 clinical trials.

Therapeutic areas: Glaucoma, Ocular Hypertension, Eye Disease.

Sponsors: Amakem, NV.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Haven Clinical Site - Site 01?

New Haven Clinical Site - Site 01 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Haven Clinical Site - Site 01 conducted?

New Haven Clinical Site - Site 01 has 1 clinical trials on record. Their work covers Glaucoma, Ocular Hypertension, Eye Disease.

Is New Haven Clinical Site - Site 01 accredited by Crixeo Health?

New Haven Clinical Site - Site 01 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Haven Clinical Site - Site 01?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.